Pregabalin API, the active pharmaceutical ingredient in medications like Lyrica, is utilized for treating epilepsy, neuropathic pain, fibromyalgia, and generalized anxiety disorder. As a gamma-aminobutyric acid (GABA) analog, it exerts its therapeutic effects by binding to calcium channels in the central nervous system, specifically the alpha-2-delta subunit of voltage-gated calcium channels. This interaction modulates neurotransmitter release, contributing to pain relief and seizure control. Pregabalin API is the pure form of pregabalin employed in the formulation of pharmaceutical products such as capsules or tablets. For inquiries regarding manufacturing, regulatory aspects, or availability, consulting pharmaceutical professionals or regulatory agencies is advised.